-
EP1175405
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1175405
| EP1175405 - LACTAM INHIBITORS OF FXa AND METHOD [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 08.12.2006 Database last updated on 19.07.2024 | Most recent event Tooltip | 25.07.2008 | Change - representative | published on 27.08.2008 [2008/35] | Applicant(s) | For all designated states Bristol-Myers Squibb Company Route 206 and Province Line Road Princeton, NJ 08543 / US | [N/P] |
| Former [2002/05] | For all designated states BRISTOL-MYERS SQUIBB COMPANY P.O. Box 4000 Princeton, NJ 08543-4000 / US | Inventor(s) | 01 /
BISACCHI, Gregory, S. 130 Mountain Road Ringoes, NJ 08551 / US | 02 /
SEILER, Steven, M. 101 North Main Street Pennington, NJ 08534 / US | 03 /
LAWRENCE, R., Michael 48 W. Crown Terrace Yardley, PA 19067 / US | [2002/05] | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [2008/35] | Vossius & Partner Siebertstrasse 3 81675 München / DE | ||
| Former [2002/05] | VOSSIUS & PARTNER Siebertstrasse 4 81675 München / DE | Application number, filing date | 00904564.2 | 27.01.2000 | [2002/05] | WO2000US01859 | Priority number, date | US19990119374P | 09.02.1999 Original published format: US 119374 P | [2002/05] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO0047563 | Date: | 17.08.2000 | Language: | EN | [2000/33] | Type: | A1 Application with search report | No.: | EP1175405 | Date: | 30.01.2002 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.08.2000 takes the place of the publication of the European patent application. | [2002/05] | Search report(s) | International search report - published on: | US | 17.08.2000 | (Supplementary) European search report - dispatched on: | EP | 28.03.2002 | Classification | IPC: | C07K5/06, A61P7/02, C07D223/06, C07D401/02, C07D403/02, A61K31/4427, A61K31/496, A61K31/55 | [2002/20] | CPC: |
C07K5/06139 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
A61P9/00 (EP);
C07K5/06191 (EP);
A61K38/00 (EP)
|
| Former IPC [2002/05] | C07D223/06, C07D401/02, C07D403/02, A61K31/4427, A61K31/496, A61K31/55 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/05] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | RO | Not yet paid | SI | Not yet paid | Title | German: | LACTAMINHIBITOREN VON FXa UND VERFAHREN | [2002/05] | English: | LACTAM INHIBITORS OF FXa AND METHOD | [2002/05] | French: | INHIBITEURS LACTAME DU FACTEUR Xa ET METHODE ASSOCIEE | [2002/05] | Entry into regional phase | 10.09.2001 | National basic fee paid | 10.09.2001 | Search fee paid | 10.09.2001 | Designation fee(s) paid | 10.09.2001 | Examination fee paid | Examination procedure | 21.07.2000 | Request for preliminary examination filed International Preliminary Examining Authority: US | 10.09.2001 | Amendment by applicant (claims and/or description) | 10.09.2001 | Examination requested [2002/05] | 05.08.2003 | Despatch of a communication from the examining division (Time limit: M09) | 06.05.2004 | Reply to a communication from the examining division | 31.05.2005 | Despatch of a communication from the examining division (Time limit: M06) | 21.10.2005 | Reply to a communication from the examining division | 24.11.2006 | Application withdrawn by applicant [2007/02] | 24.11.2006 | Cancellation of oral proceeding that was planned for 21.03.2007 | 24.11.2006 | Minutes of oral proceedings despatched | 21.03.2007 | Date of oral proceedings (cancelled) | Fees paid | Renewal fee | 14.01.2002 | Renewal fee patent year 03 | 14.01.2003 | Renewal fee patent year 04 | 14.01.2004 | Renewal fee patent year 05 | 12.01.2005 | Renewal fee patent year 06 | 12.01.2006 | Renewal fee patent year 07 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]WO9535311 (CORVAS INT INC [US], et al) [X] 1,2,12,14-16 * page 44, lines 20-25; examples 28, 30, 32-36, 40, 84, B7; table 3 on page 114 *; | [A]WO9816523 (COR THERAPEUTICS INC [US]) [A] 1,2,5,14-16 * page 13, lines 11-14; page 24, line 5; page 25, line 4; examples 13 and 14 *; | [E]WO0015222 (BRISTOL MYERS SQUIBB CO [US]) [E] 1,5 * abstract; page 78, compound 149 with page 70, lines 1-3 and formula II on page 3; claim 15 *; | [A] - ADANG A E P ET AL, "Novel acylguanidine containing thrombin inhibitors with reduced basicity at the P1 moiety", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, (19981215), vol. 8, no. 24, ISSN 0960-894X, pages 3603 - 3608, XP004150375 [A] 1,2,14-16 * table 2; page 3604, last paragraph * DOI: http://dx.doi.org/10.1016/S0960-894X(98)00650-7 | International search | [X]US5155102 ; | [A]US5672598 ; | [A]WO9611940 |